SFEのチャート
SFEの企業情報
| symbol | SFE |
|---|---|
| 会社名 | Safeguard Scientifics Inc. （SAFEGUARD SCIEN） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 投資管理_ファンドオペレ―タ― 金融（Financials） |
| 概要 | セーフガード・サイエンティフィックス(Safeguard Scientifics Inc.)はヘルスケア、金融サービス、デジタルメディア分野のテクノロジー企業に資本を提供する。同社はパートナー企業と呼ばれる企業に所有権を有する。同社は各パートナー企業に経営支援を提供している。管理および運営上のサポートに加えて、同社は継続的な計画および開発の評価を提供している。同社はパートナー企業の管理を発展させるための指導、アドバイスを提供する。同社はパートナー企業の取締役会にサービスを提供し、戦略的および事業計画の策定および実施に協力している。同社は運用上および財務上のパフォーマンス測定値の定期的なレビューを通じて、計画の達成度を測定および監視する。 セ―フガ―ド・サイエンティフィックスは米国内の成長企業や初期段階の新興企業に投資を行う。分子遺伝学、特殊医薬品、医療IT、デジタル医療機器などの医療技術のほか、デジタルメディア、金融IT、オンライン小売り、次世代業務用アプリケ―ション、モバイル技術の分野に焦点を置く。 Historically, Safeguard Scientifics (NYSE:SFE) has provided capital and relevant expertise to fuel the growth of technology-driven businesses. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades. Currently, Safeguard is pursuing a focused strategy to value-maximize and monetize its ownership interests over a multiyear time frame to drive shareholder value. |
| 本社所在地 | 170 North Radnor-Chester Road Suite 200 Radnor PA 19087 USA |
| 代表者氏名 | Robert J. Rosenthal |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 610-293-0600 |
| 設立年月日 | 19603 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | － |
| url | www.safeguard.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） -16.87100 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 225.31700 |
| 売上高 | （百万ドル） 0.00000 |
| 企業価値(EV) | （百万ドル） 249.83300 |
| 当期純利益 | （百万ドル） -15.62900 |
| 決算概要 | BRIEF: For the fiscal year ended 31 December 2018 Safeguard Scientifics Inc revenues was not reported. Net loss decreased 82% to $15.6M. Lower net loss reflects Equity income (loss) increase from $66.4M (expense) to $19.7M (income) Stock-Based Compensation - SG& A decrease of 15% to $966K (expense) General and administrative expense - Bal decrease of 1% to $15.9M (expense). |
SFEのテクニカル分析
SFEのニュース
Allbirds And 3 Other Stocks Under $2 Insiders Are Aggressively Buying 2023/03/17 11:13:59 Benzinga
The Dow Jones closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Safeguard Scientifics The Trade: Safeguard Scientifics, Inc. (NASDAQ: SFE ) 10% owner Thomas A. Satterfield acquired a total of 127,078 shares an average price of $1.79. To acquire these shares, it cost around $226.98 thousand. What’s Happening: Safeguard Scientifics posted a Q4 loss of $0.30 per share. What Safeguard Scientifics … Full story available on Benzinga.com
Safeguard Scientifics, Inc. (SFE) Q4 2022 Earnings Call Transcript 2023/03/10 23:20:02 Seeking Alpha
Safeguard Scientifics, Inc. (NASDAQ:NASDAQ:SFE) Q4 2022 Results Conference Call March 9, 2023 5:00 PM ETCompany ParticipantsMatt Barnard - General CounselEric Salzman - CEOMark Herndon -…
Safeguard Scientifics GAAP EPS of -$0.30 2023/03/09 22:17:06 Seeking Alpha
Safeguard Scientifics press release (SFE): Q4 GAAP EPS of -$0.30.Safeguard expects follow-on deployments for its remaining ownership interests for 2023 to be in a range of $4 million…
Safeguard Scientifics Announces Fourth Quarter and Year End 2022 Financial Results 2023/03/09 21:15:00 GlobeNewswire
Conference call and webcast on March 9, 2023 at 5 p.m. ET Conference call and webcast on March 9, 2023 at 5 p.m. ET
SAFEGUARD SCIENTIFICS ANNOUNCES COMPLETION OF SHARE REPURCHASE PROGRAM 2023/01/10 13:00:00 GlobeNewswire
RADNOR, Pa., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) (“Safeguard” or the “Company”) today announced the completion of the $3 million share repurchase program announced in March 2022.
SAFEGUARD SCIENTIFICS ANNOUNCES COMPLETION OF SHARE REPURCHASE PROGRAM 2023/01/10 13:00:00 GlobeNewswire
RADNOR, Pa., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) (“Safeguard” or the “Company”) today announced the completion of the $3 million share repurchase program announced in March 2022.
Safeguard Scientifics, Inc. (SFE) Q3 2022 Earnings Call Transcript 2022/11/06 15:58:05 Seeking Alpha
Safeguard Scientifics, Inc. (NASDAQ:NASDAQ:SFE) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Matt Barnard - General Counsel and Secretary Eric Salzman -…
Safeguard Scientifics Announces Third Quarter 2022 Financial Results 2022/11/03 20:15:00 GlobeNewswire
Conference call and webcast on November 3, 2022 at 5 p.m. ET Conference call and webcast on November 3, 2022 at 5 p.m. ET
Safeguard Scientifics, Inc. (SFE) CEO Eric Salzman on Q2 2022 Results - Earnings Call Transcript 2022/08/12 03:45:06 Seeking Alpha
Safeguard Scientifics, Inc. (NYSE:NYSE:SFE) Q2 2022 Earnings Conference Call August 11, 2022 05:00 PM ET Company Participants Matthew Barnard - General Counsel Eric Salzman - CEO Mark…
Safeguard Scientifics GAAP EPS of $0.03 2022/08/11 20:36:01 Seeking Alpha
Safeguard Scientifics press release (SFE): Q2 GAAP EPS of $0.03.Cash, cash equivalents and restricted cash totaled $17.5 million at June 30, 2022.
Safeguard Scientifics, Inc. (SFE) CEO Eric Salzman on Q2 2022 Results - Earnings Call Transcript 2022/08/12 03:45:06 Seeking Alpha
Safeguard Scientifics, Inc. (NYSE:NYSE:SFE) Q2 2022 Earnings Conference Call August 11, 2022 05:00 PM ET Company Participants Matthew Barnard - General Counsel Eric Salzman - CEO Mark…
Safeguard Scientifics GAAP EPS of $0.03 2022/08/11 20:36:01 Seeking Alpha
Safeguard Scientifics press release (SFE): Q2 GAAP EPS of $0.03.Cash, cash equivalents and restricted cash totaled $17.5 million at June 30, 2022.
Safeguard Scientifics Announces Second Quarter 2022 Financial Results 2022/08/11 20:15:00 GlobeNewswire
Conference call and webcast on August 11, 2022 at 5 p.m. ET Conference call and webcast on August 11, 2022 at 5 p.m. ET
SAFEGUARD SCIENTIFICS TO RELEASE SECOND QUARTER 2022 FINANCIAL RESULTS ON THURSDAY, AUGUST 11th 2022/08/02 20:30:00 GlobeNewswire
Conference Call and Webcast Scheduled for Thursday, August 11th at 5:00 pm ET Conference Call and Webcast Scheduled for Thursday, August 11th at 5:00 pm ET
Syapse Raises $35M in Growth Funding 2022/07/28 07:07:32 FinSMEs
Syapse, a San Francisco, CA and New York-based evidence company dedicated to advancing real-world care, raised $35M in Growth funding. The round was led by Innovatus Capital Partners, with participation from existing investors including Ally Bridge Group, Merck Global Health Innovation Fund, Northpond Ventures, Revelation Alpine LLC, Safeguard Scientifics, and Social Capital. The company intends […] The post Syapse Raises $35M in Growth Funding appeared first on FinSMEs .